1. Home
  2. PD vs RLAY Comparison

PD vs RLAY Comparison

Compare PD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$14.45

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$17.58

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
RLAY
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
4.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PD
RLAY
Price
$14.45
$17.58
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$12.63
★ $19.50
AVG Volume (30 Days)
1.6M
★ 3.0M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 416.95
31.78
EPS
★ 0.19
N/A
Revenue
★ $492,546,000.00
$15,355,000.00
Revenue This Year
$3.58
N/A
Revenue Next Year
$2.88
$324.03
P/E Ratio
$78.68
★ N/A
Revenue Growth
5.36
★ 53.44
52 Week Low
$5.70
$5.01
52 Week High
$16.91
$21.27

Technical Indicators

Market Signals
Indicator
PD
RLAY
Relative Strength Index (RSI) 59.96 38.54
Support Level $12.78 $11.68
Resistance Level $14.67 $20.29
Average True Range (ATR) 0.51 0.85
MACD -0.05 -0.13
Stochastic Oscillator 70.83 13.77

Price Performance

Historical Comparison
PD
RLAY

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: